Save the Cord Foundation and WellSky are proud to welcome Josefine Teeler, as our featured speaker for our next edition of Share the Science on December 12th, 2019.
Share the Science is a free webinar series focused on the cord blood industry and the latest research in this field. As always, we invite both health professionals and the general public to join us for this unique online educational series. Learn more about this exciting educational series here.
How is Cord Blood matched for Stem Cell Transplants?
Human Leukocyte Antigens (HLA) matching for Cord Blood Units (CBU) is much more complex than blood typing. This webinar will cover how to find the best match and what information is needed to select the most optimal CBU based on HLA profiles. Josefine Teeler, Team Lead - Transplant Center Services for Matchis Foundation will provide information on how matchgrade is determined for CBUs and the guidelines for selection.
She will also discuss the differences between n/6, n/8, and n/10 matchgrade. Attendees will also learn about minimal matchgrade and (permissive) mismatches. By choosing the best CBU for a patient not only HLA is considered, so therefore we will also briefly review the balance between matchgrade, cell dose and diagnosis of the patient.
What will you learn in this webinar?
Attendees of this Share the Science webinar will learn about cord blood unit selection based on HLA profiles and matchgrade. Josefine will explain how matchgrade is determined. She will go into detail regarding minimal matchgrade and how this is influenced by cell dose and/or diagnosis. She will review global guidelines as well as the characteristics and types of information regarding the HLA profiles that influence the final cord blood unit selection.
SHARE THE SCIENCE
Search Unit Team Leader at
"HLA Matching for Cord Blood"
Free webinar. Open to the public.
Thursday, December 12th, 2019 - 12pm Central Daylight Time
About the Speaker
Josefine Teeler is search unit team lead at Matchis foundation. She is also a search consultant performing analysis of patient’s profiles and Matched Unrelated Donor (MUD) and/or Cord Blood Units (CBU) selections on a daily basis. She advises physicians and clinical immunologists in the Netherlands on selecting the best possible product/donor for their patient taking into account HLA profiles, secondary criteria, virology, accreditation status of registries and (local) legislations.
At Matchis she is also responsible for the development of the internal educational program for new search coordinators and other employees. Apart from these activities, she developed educational materials for students from primary and secondary school regarding the subject Stem Cell transplantation. Ms. Teeler is also involved in the educational committee of the WMDA and is working together with other WMDA members on the revision of the international paper regarding the Search Coordinator job description.
* * *
We wish to thank Josefine Teeler for volunteering her time to speak on
Share the Science and sharing her valuable insight on HLA matching for cord blood.
We also wish to thank our generous sponsor and partner for this event,
WellSky Health (formerly known as Mediware, Inc.), who continue to support cord blood
education through our “Share the Science” series.
Let's bust some cord blood myths!!! The experts have spoken! Here is your chance to learn the facts on this life-saving medical resource. Discover our new educational video series: Cord Blood Myths - BUSTED!
Save the Cord Foundation and Cord Blood Association (CBA) have come together for an exclusive educational project designed to dispel some of the most common myths or misunderstandings regarding cord blood. Working as a team, we interviewed key leaders and experts in the cord blood industry and several cord blood transplant recipients. The questions were collected and curated by CBA. The interviews were led by Charis Ober, Executive Director of Save the Cord Foundation, during the inaugral Cord Blood Connect meeting in Miami, Florida. To date, we have produced 9 videos highlighting a selection of the common cord blood myths provided by CBA.
We recommend you begin exploring this educational series by watching this interview with Dr. Colleen Delaney and her patient, Gregg Gordon.
Share the Science with Ed Brindle: "Proper Lab Sanitization for the Cord Blood Processing Laboratory"
Save the Cord Foundation and Mediware, Inc. are proud to welcome Ed Brindle for our next edition of Share the Science on June 26th, 2018. Share the Science is a free webinar series focused on the cord blood industry and the latest research in this field. As always, we invite both health professionals and the general public to join us for this unique online educational series.
Collecting cord blood is simple. However, just like the collection of organs for transplant there are several rules that must be followed in order to ensure the quality and safety of the collection. When these criteria are not met, it can put patients at risk, make the collection useless or potentially destroy the collection. Keeping the cord blood processing laboratory clean, sanitized, and disinfected is crucial to product quality and safety. Although there is industry guidance for cleaning procedures, laboratory practices often vary depending on location, regulatory requirements, product type, and facility design. In addition, cord blood banks must always have an eye on the future and the potential new applications for cord blood stem cells in regenerative medicine, immunotherapy, expansion, etc. These future applications will have new requirements, yet the cord blood to be used for those applications is probably being collected now. Hence, there is a constant need to be one step ahead of the requirements and to think strategically about your cord blood bank's collection processing in the laboratory.
How can your cord blood bank be prepared for the new demands of the industry? Imagine the disappointment if one of your clients who required their collection in the future for one of these new therapies was refused simply because the processing did not meet requirements. Are you providing the best in cord blood processing for your clients and potential patients?
In this edition of Share the Science, we welcome Ed Brindle who is Director of Quality and Regulatory Affairs for Insception Lifebank, co-chair of both the American Association of Blood Banks (AABB) standards committee and the Cord Blood Processing Standards’ Foundation for the Accreditation of Cellular Therapy (FACT) committee. He will highlight the best practices used by successful cord blood processing laboratories and illustrates how you can implement them at your facility. The discussion will also look to the future and consider the implications of potential advances in cord research on your lab's cord blood collection criteria and processing.
As an attendee of this webinar, you will also have an opportunity to ask questions directly to Mr. Brindle.
Highlights of this webinar will include:
Share the Science
“How to Ensure Proper Lab Sanitization for
Cord Blood Processing Laboratory”
Tuesday, June 26th, 2018 2pm CST
Free to register. Open to the public.
RECORDING NOW AVAILABLE
About the Speaker
This informative session is presented by Ed Brindle. With more than 20 years combined experience in clinical laboratory sciences and cellular therapies both in United Kingdom and Canada, Mr. Brindle is the Director of Quality and Regulatory Affairs for Insception Lifebank. Mr. Brindle is also co-chair of both the American Association of Blood Banks (AABB) standards committee and the Cord Blood Processing Standards’ Foundation for the Accreditation of Cellular Therapy (FACT) committee.
Mr. Brindle is a Qualified NetCord FACT Cord Blood Processing Inspector and actively carries out inspections of International FACT Accredited Cord Blood Banks for compliance to current NetCord FACT Standards. He is also an active member of the Cord Blood Processing standards committee. In addition, Mr. Brindle is active as a Cord Blood and CT assessor with the AABB. He routinely carries out the assessment of various National and International Cell therapy facilities to ensure compliance with the current AABB Cellular Therapy Standards.
* * *
We wish to thank Ed Brindle for volunteering his time to speak on
Share the Science and sharing his valuable insight on cord blood collection processing.
We also wish to thank our generous sponsors, Mediware Inc., who continue
to support cord blood education through our “Share the Science” series.
Explore the Share the Science Archive:
Share the Science continues to be a popular series within the cord blood community and beyond. We welcome your input on the series and suggestions for future speakers. Give your feedback here.
Previous Share the Science presentations have been archived for your reference. Discover the work of leading scientists and cord blood industry experts through this educational series. View the archive now.
Get Involved. Join the #cordbloodmovement!
Save the Cord Foundation thrives on passionate people like yourself
who are eager to share what they have learned about cord blood with others.
Whether you are a teacher, parent, doctor, nurse or researcher. . . you can make a difference!
Join us on social media and share your favorite article or program from Save the Cord Foundation.
Give us a shout when you do and we will let the world know that you are doing your part!
Cord blood saves lives. Spread the word.
Write something about yourself. No need to be fancy, just an overview.